U.S. delays decision on COVID vaccine for children under 5 by at least 2 months

A man can be seen receiving a COVID-19 vaccination in this undated photo. (File Photo: Jordan News)
(Photo: Jordan News)
AMMAN—A U.S. decision on Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data, according to the Jordan News Agency, Petra.اضافة اعلان

The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21.

On Friday, the agency said it had reviewed new trial information that had come in since Pfizer and BioNTech's request for emergency authorization and decided it needed more data before moving forward.

The FDA said parents anxiously awaiting the vaccine for their younger kids should be reassured that the agency is taking the time to make sure it meets the standard it has set for authorization.

Read more Region and World news.